Pulmonx Corp. (LUNG) on GreekSoup https://greeksoup.ai/stocks/us/lung/ Every dated entry in the public record on Pulmonx Corp.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Pulmonx Corp. Q3 FY2026 results: revenue $23 million, net income -$8 million (from its press release)https://greeksoup.ai/stocks/us/lung/results/fy2026-q3/us:LUNG:result:2026-10-27:1a5fa76294Tue, 27 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Pulmonx Corp. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/lung/filings/us:LUNG:filing:2026-10-27:7efdfb94dbTue, 27 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: short interest 698,644 shares at the 15 October 2026 settlement, 2.54 days to coverhttps://greeksoup.ai/stocks/us/lung/short-interest/us:LUNG:short-interest:2026-10-15:25cbe29afeThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: short interest 802,733 shares at the 30 September 2026 settlement, 3.20 days to coverhttps://greeksoup.ai/stocks/us/lung/short-interest/us:LUNG:short-interest:2026-09-30:cb36cba041Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: short interest 847,842 shares at the 15 September 2026 settlement, 2.51 days to coverhttps://greeksoup.ai/stocks/us/lung/short-interest/us:LUNG:short-interest:2026-09-15:8054852b07Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: French Glendon E. Iii (President and CEO) sold 4,098 shares at $2.26 on 1 September 2026, $9,261https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:93b5e08618Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: French Glendon E. Iii (President and CEO) sold 37,784 shares at $2.26 on 1 September 2026, $85,392https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:6aee2a3c1eThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Radhakrishnan Srikanth (Chief Science & Techn. Officer) sold 2,643 shares at $2.26 on 1 September 2026, $5,973https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:aa99871752Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Radhakrishnan Srikanth (Chief Science & Techn. Officer) sold 2,121 shares at $2.26 on 1 September 2026, $4,793https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:8fdb21d3c6Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Radhakrishnan Srikanth (Chief Science & Techn. Officer) sold 3,618 shares at $2.26 on 1 September 2026, $8,177https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:6b04c2c1a7Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Radhakrishnan Srikanth (Chief Science & Techn. Officer) sold 5,863 shares at $2.26 on 1 September 2026, $13,250https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:8830645b57Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Lehman David Aaron (General Counsel) sold 3,807 shares at $2.26 on 1 September 2026, $8,604https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:3887a22cd5Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Lehman David Aaron (General Counsel) sold 2,224 shares at $2.26 on 1 September 2026, $5,026https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:ecae62ba5dThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Lehman David Aaron (General Counsel) sold 3,476 shares at $2.26 on 1 September 2026, $7,856https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:7420df48a0Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Lehman David Aaron (General Counsel) sold 4,827 shares at $2.26 on 1 September 2026, $10,909https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:64e91f279bThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Rose Geoffrey Beran (Chief Commercial Officer) sold 2,213 shares at $2.26 on 1 September 2026, $5,001https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:bc068f5ea5Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Rose Geoffrey Beran (Chief Commercial Officer) sold 2,390 shares at $2.26 on 1 September 2026, $5,401https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:cacde30ef3Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Rose Geoffrey Beran (Chief Commercial Officer) sold 1,530 shares at $2.26 on 1 September 2026, $3,458https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:3396a3443fThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Rose Geoffrey Beran (Chief Commercial Officer) sold 1,746 shares at $2.26 on 1 September 2026, $3,946https://greeksoup.ai/stocks/us/lung/insiders/us:LUNG:insider:2026-09-03:3f9e808241Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: short interest 976,237 shares at the 31 August 2026 settlement, 2.58 days to coverhttps://greeksoup.ai/stocks/us/lung/short-interest/us:LUNG:short-interest:2026-08-31:7a2ee54d54Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: short interest 1,066,574 shares at the 14 August 2026 settlement, 1.18 days to coverhttps://greeksoup.ai/stocks/us/lung/short-interest/us:LUNG:short-interest:2026-08-14:ff9bf48d85Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Pulmonx Corp.: Schedule 13G/A filed by Morgan Stanley, 6.9% of the classhttps://greeksoup.ai/stocks/us/lung/holders/us:LUNG:schedule-13:2026-08-13:03cc8232a9Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Pulmonx Corp. Q2 FY2026 results: revenue $23 million, net income -$10 millionhttps://greeksoup.ai/stocks/us/lung/results/fy2026-q2/us:LUNG:result:2026-08-04:36a06b0128Tue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Pulmonx Corp. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/lung/filings/us:LUNG:filing:2026-08-04:3517c30f8dTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>